Back to Search
PAUL HARRIOTT, MD
MD
Orthopaedic Surgery Physician
NPI: 1215967039IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
C10006103(DE)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
HARVARD MEDICAL SCHOOL
Class of 1995
Research & Publications (20)
Role of CD4(+) and CD8(+) T cells in the prevention of measles virus-induced encephalitis in mice.
PMID 11038383·J Gen Virol·2000
7-preclinical
Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges.
PMID 17548109·Mol Immunol·2008
8-other
IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100B.
PMID 18587628·Mol Cell Biochem·2008
8-other
Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
PMID 17320856·Eur J Pharmacol·2007
7-preclinical
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
PMID 17486314·Diabetologia·2007
7-preclinical
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide.
PMID 17315241·Diabetes Metab Res Rev·2007
7-preclinical
Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice.
PMID 17184947·Exp Gerontol·2007
7-preclinical
Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes.
PMID 17261080·Biol Chem·2007
7-preclinical
Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonists.
PMID 17428436·Arch Biochem Biophys·2007
7-preclinical
Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background.
PMID 17171334·Exp Brain Res·2007
7-preclinical
Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob mice.
PMID 17299087·Am J Physiol Endocrinol Metab·2007
4-observational
Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.
PMID 16784461·Chem Biol Drug Des·2006
7-preclinical
Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide.
PMID 16859646·Biochem Pharmacol·2006
7-preclinical
Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
PMID 16648370·J Pharmacol Exp Ther·2006
7-preclinical
GIP(Lys16PAL) and GIP(Lys37PAL): novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potential.
PMID 16451070·J Med Chem·2006
7-preclinical
Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
PMID 17065392·J Endocrinol·2006
7-preclinical
Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice.
PMID 16181707·Peptides·2006
7-preclinical
The inactivation of bovine cathepsin B by novel N-chloro-acetyl-dipeptides: application of the Houghten 'tea bag' methodology to inhibitor synthesis.
PMID 15978544·Biochem Biophys Res Commun·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1606 SAVANNAH RD
LEWES, DE 19958 - Phone
- (410) 749-4154
Quick Facts
- NPI
- 1215967039
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile